Fischer Medical Ventures' portfolio company, Nanomedic, achieved significant milestones for its SpinCare® wound care solution. It secured UK NHS registration, opening access to a major healthcare system and expanding its presence to 34 countries. In India, Nanomedic completed device registration documentation and submitted its commercial import license application, initiating hospital trials. The company is also strengthening its leadership team and preparing for its next US FDA filing, with an outcome expected in Q4. These developments, supported by compelling clinical validation, validate FMVL's investment strategy and position SpinCare® for substantial global growth in advanced wound care.